Kevin P. Carlin

Kevin P. Carlin has a strong background in the pharmaceutical industry with over 25 years of experience. Kevin P. is currently serving as the Vice President of Sales for Solid Tumors at Stemline Therapeutics since January 2023. Prior to that, they held the position of Vice President of Sales for the US Oncology Business Unit at Takeda from October 2019 to January 2023.

Before joining Takeda, Kevin worked at Takeda Oncology for 13 years, where they served as the National Sales Director for the Solid Tumor Team from October 2017 to October 2019, and as the Area Director of Sales for Hematology from September 2006 to October 2017.

Their earlier experience includes working as a Regional Sales Manager at Millennium Pharmaceuticals from November 2005 to September 2006. Prior to that, they held multiple roles at Amgen from April 2002 to November 2005 and at GlaxoSmithKline Pharma GmbH from April 1997 to April 2002.

Kevin began their career as an Account Executive at Mid Atlantic Medical Services, Inc. in May 1996, where they worked until April 1997.

Kevin P. Carlin obtained a Bachelor of Arts (B.A.) degree in Political Science from Marquette University.